Association between maternal inflammatory bowel disease and adverse perinatal outcomes

Journal of Perinatology

Volumn 34, Issue 6, 2014, Pages 435-440

  Getahun, D ^a,b   Fassett, M J ^c   Longstreth, G F ^a   Koebnick, C ^a   Langer Gould, A M ^a   Strickland, D ^a   Jacobsen, S J ^a  

^a KAISER PERMANENTE   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c West Los Angeles Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MESALAZINE;

ADULT; ADVERSE OUTCOME; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FETUS OUTCOME; HIGH RISK PREGNANCY; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; ISCHEMIC PLACENTAL DISEASE; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; MATERNAL SMOKING; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PERINATAL PERIOD; PLACENTA DISORDER; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RACE DIFFERENCE; RISK ASSESSMENT; SMALL FOR DATE INFANT; ULCERATIVE COLITIS; COMPLICATION; EPIDEMIOLOGY; FETAL MEMBRANES, PREMATURE RUPTURE; INCIDENCE; MOTHER; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE BIRTH; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; YOUNG ADULT;

ADULT; CALIFORNIA; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84901805882     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2014.41     Document Type: Article

References (37)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142(1): 46-54 e42.
2. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007; 5(12): 1424-1429. (Pubitemid 350181588)
3. Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S et al. Review article: mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol Ther 2001; 15(3): 337-346. (Pubitemid 32187555)
4. Hermon-Taylor J. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut 2001; 49(6): 755-756. (Pubitemid 33096029)
5. Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 1996; 348(9026): 515-517. (Pubitemid 26279014)
6. Thompson NP, Montgomery SM, Wadsworth ME, Pounder RE, Wakefield AJ. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol 2000; 12(1): 25-30. (Pubitemid 30072101)
7. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease(EC-IBD). Gut 1996; 39(5): 690-697. (Pubitemid 26426470)
8. Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996; 111(3): 597-603. (Pubitemid 26293222)
9. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40(8): 955-962.
10. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006; 101(7): 1559-1568. (Pubitemid 43980630)
11. Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease-findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989; 18(1): 105-107. (Pubitemid 19128640)
12. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease-a population-based cohort study. Am J Obstet Gynecol 1997; 177(4): 942-946. (Pubitemid 27516071)
13. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK et al. A meta-analysis on the influence of inflammatory bowel diseaseon pregnancy. Gut 2007; 56(6): 830-837. (Pubitemid 46854200)
14. Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007; 102(7): 1406-1413. (Pubitemid 46976292)
15. Farmer RG, Hawk WA, Turnbull RB, Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975; 68(4 Pt 1): 627-635.
16. Kornbluth A, Sachar DB. Practice Parameters Committee of the American College of G. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99(7): 1371-1385. (Pubitemid 39062279)
17. Hillier SL, Krohn MA, Kiviat NB, Watts DH, Eschenbach DA. Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol 1991; 165(4 Pt 1): 955-961.
18. Ananth CV, Peltier MR, Getahun D, Kirby RS, Vintzileos AM. Primiparity: an 'intermediate' risk group for spontaneous and medically indicated preterm birth. J Matern Fetal Neonatal Med 2007; 20(8): 605-611. (Pubitemid 47221560)
19. Getahun D, Rhoads GG, Fassett MJ, Chen W, Strauss JA, Demissie K et al. Accuracy of reporting maternal and infant perinatal service system coding and clinical utilization coding. J Med Stat Inform 2013; 1: 3.
20. Wellcome Trust Case Control C. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007; 447(7145): 661-678.
21. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002; 97(3): 641-648. (Pubitemid 34245893)
22. Nguyen GC, Boudreau H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009; 7(3): 329-334.
23. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004; 15(4): 237-241. (Pubitemid 38686012)
24. Vessey M, Jewell D, Smith A, Yeates D, McPherson K. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. Br Med J (Clin Res Ed) 1986; 292(6528): 1101-1103. (Pubitemid 16110633)
25. Klement E, Cohen RV, Boxman J, Joseph A, Reif S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 2004; 80(5): 1342-1352.
26. Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci 1999; 44(1): 1-13. (Pubitemid 29053071)
27. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85(3): 430-434. (Pubitemid 32233013)
28. Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastro-enterol Hepatol 2008; 6(1): 41-45. (Pubitemid 50008413)
29. Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N et al. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int 2006; 26(7): 663-668.
30. Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 2006; 6(3): 244-251. (Pubitemid 43290993)
31. Herrinton LJ, Liu L, Fireman B, Lewis JD, Allison JE, Flowers N et al. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology 2009; 137(2): 502-511.
32. Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 2004; 99(4): 656-661. (Pubitemid 38607969)
33. Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J. Incidence and prevalence of inflammatory bowel diseasein a Northern California managed care organization, 1996-2002. Am J Gastroenterol 2008; 103(8): 1998-2006.
34. Loftus CG, Loftus EV Jr., Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13(3): 254-261. (Pubitemid 46465905)
35. Getahun D, Ananth CV, Oyelese Y, Chavez MR, Kirby RS, Smulian JC. Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies. Obstet Gynecol 2007; 110(6): 1319-1325. (Pubitemid 351326076)
36. Hedderson MM, Gunderson EP, Ferrara A. Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol 2010; 115(3): 597-604.
37. Buka SL, Shenassa ED, Niaura R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry 2003; 160(11): 1978-1984. (Pubitemid 39619634)